Sarah Howell
Chief Executive Officer bij ARECOR THERAPEUTICS PLC
Vermogen: 2 M $ op 31-03-2024
Profiel
Sarah Jennifer Howell is currently the Chief Executive Officer & Director at Arecor Ltd.
and the Chief Executive Officer & Executive Director at Arecor Therapeutics Plc.
Previously, she held positions as the Director-Outsourced Manufacturing & Biologics at UCB SA, Team Leader at GSK Plc, and VP-Chemistry, Manufacturing & Controls at BTG Ltd.
She obtained an undergraduate degree from the University of Birmingham and a doctorate degree from the University of St. Andrews.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ARECOR THERAPEUTICS PLC
2.83% | 16-11-2022 | 867 738 ( 2.83% ) | 2 M $ | 31-03-2024 |
Actieve functies van Sarah Howell
Bedrijven | Functie | Begin |
---|---|---|
ARECOR THERAPEUTICS PLC | Chief Executive Officer | - |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | 01-01-2015 |
Eerdere bekende functies van Sarah Howell
Bedrijven | Functie | Einde |
---|---|---|
UCB | Corporate Officer/Principal | - |
GSK PLC | Corporate Officer/Principal | - |
BTG | Corporate Officer/Principal | - |
Opleiding van Sarah Howell
University of Birmingham | Undergraduate Degree |
University of St. Andrews | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
GSK PLC | Health Technology |
UCB | Health Technology |
ARECOR THERAPEUTICS PLC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |